Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Research & Development: 2023-2025

Historic Research & Development for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $33.0 million.

  • Upstream Bio's Research & Development rose 113.67% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.4 million, marking a year-over-year increase of 124.49%. This contributed to the annual value of $63.0 million for FY2024, which is 98.01% up from last year.
  • According to the latest figures from Q3 2025, Upstream Bio's Research & Development is $33.0 million, which was down 12.91% from $37.9 million recorded in Q2 2025.
  • Upstream Bio's 5-year Research & Development high stood at $37.9 million for Q2 2025, and its period low was $7.8 million during Q3 2023.
  • For the 3-year period, Upstream Bio's Research & Development averaged around $19.9 million, with its median value being $15.4 million (2024).
  • Data for Upstream Bio's Research & Development shows a peak YoY surged of 169.14% (in 2025) over the last 5 years.
  • Over the past 3 years, Upstream Bio's Research & Development (Quarterly) stood at $11.6 million in 2023, then skyrocketed by 88.45% to $21.8 million in 2024, then surged by 113.67% to $33.0 million in 2025.
  • Its Research & Development stands at $33.0 million for Q3 2025, versus $37.9 million for Q2 2025 and $25.8 million for Q1 2025.